Render Target: SSR
Render Timestamp: 2025-03-17T06:01:20.392Z
Commit: a619ae74f66dae0f27639e88da12bcf600e46428
XML generation date: 2024-09-12 14:38:50.599
Product last modified at: 2024-09-13T07:01:41.713Z
1% for the planet logo
PDP - Template Name: Generic
PDP - Template ID: *******d755eaf

PTPN7 Phosphatase #8006

PTPN7 Phosphatase: Image 1
Figure 2. PTPN7 phosphatase activity was measured in a DELFIA® assay using the following reaction conditions: 25 mM HEPES, pH 7.2, 50 mM NaCl, 2.5 mM EDTA, 5 mM DTT, 65 ng/μl BSA, Substrate: Phospho-Poly (Glu-Tyr) Biotinylated Peptide #1586 at 1.5 μM, and 0.125 ng/μl PTPN7.
This product is discontinued

Inquiry Info. # 8006

Please see our recommended alternatives.

Product Information

Product Description

Purified recombinant full-length human PTPN7 phosphatase, supplied as a GST fusion protein.
MW (kDa) 66000

Storage

Enzyme is supplied in 20 mM MOPS, pH7.5; 50 mM NaCl, 0.25 mM DTT, 0.1 mM PMSF, 30% glycerol, 7 mM glutathione.
Store at -80° C.
Keep on ice during use.
Avoid repeated freeze-thaw cycles.

Quality Control

The theoretical molecular weight of the GST-PTPN7 fusion protein is 66 kDa. The purified phosphatase was quality controlled for purity using SDS-PAGE followed by Coomassie stain [Fig.1]. PTPN7 phosphatase activity was determined using a DELFIA(R) assay [Fig.2].

Source / Purification

The GST-phosphatase fusion protein was produced by expressing recombinant human PTPN7 (Met1-Pro360) (GenBank Accession No. NM_002832) with an amino-terminal GST tag in E. coli. The protein was purified by one-step affinity chromatography using glutathione-agarose.

Background

Hematopoietic protein tyrosine phosphatase (HePTP, PTPN7) is a non-receptor protein tyrosine phosphatase that is expressed primarily in hematopoietic cells (1). The protein is made up of a short, amino-terminal extension that contains a conserved kinase interaction motif (KIM) and a carboxy-terminal protein tyrosine phosphatase domain (1,2). The presence of the kinase interaction motif allows PTPN7 to interact with MAPK family kinases, such as Erk1/2 and p38 MAP kinases (2,3). Reciprocal modification occurs between PTPN7 and Erk2, as the kinase phosphorylates PTPN7 at Thr45 and Ser72 while the phosphatase dephosphorylates Erk2 at Tyr185 (2). Down regulation of MAPK signaling follows removal of specific phospho-tyrosine resides from these MAPK kinases (3,4). Modification of MAPK family kinases by PTPN7 can regulate both kinase activity and localization (4).
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit our Trademark Information page.